SAM, CAM Advise On Krishna Institute of Medical Sciences' ₹1,500 crore QIP

Shardul Amarchand Mangaldas & Co. (SAM) advised Krishna Institute of Medical Sciences Limited (KIMS), one of the key healthcare corporate groups in India, on its Qualified Institutions Placement (QIP) aggregating to ₹1,500 crore (approx. USD 158 million).

Cyril Amarchand Mangaldas guided the book running lead managers on this QIP.

The QIP comprised participation from a diverse set of institutional investors, including the International Finance Corporation (IFC), as well as leading mutual funds and insurance companies such as HSBC Mutual Fund, Edelweiss Mutual Fund, Axis Mutual Fund, ICICI Prudential Life Insurance, HDFC Life Insurance and Kotak Mahindra Life Insurance.

The proceeds of the QIP are proposed to be utilised towards repayment and/or prepayment of certain outstanding borrowings availed by the Company and certain of its subsidiaries.

SAM's transaction team comprised of Prashant Gupta, Partner and National Practice Head – Capital Markets, Ruth Chenchiah, Partner, Ritika Khare, Principal Associate; Anoushka PV, Senior Associate; Anaya Jain, Associate; and Kunika Agarwal, Associate.

CAM's team was led by partner (regional co-head - capital markets - south) Reuben Chacko and partner Abhyuday Bhotika, with support from principal associates Aniran Ghosal and Sravya Surapaneni, senior associate designate Bhaskar Kumar, and associates Namita Kaushik, Eashan Agrawal and Mitali Mangalam.